Relief Therapeutics Holding AG
Symbol: 0QKQ.L
LSE
1.2
CHFMarktpreis heute
-0.1533
P/E-Verhältnis
-0.0017
PEG-Verhältnis
14.91M
MRK Kapital
- 0.00%
DIV Rendite
Relief Therapeutics Holding AG (0QKQ-L) Finanzberichte
Bilanz
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 14.6 | 19.2 | 44.8 | |||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.net-receivables | 0 | 2.8 | 2.3 | 2.7 | |||||||||
balance-sheet.row.inventory | 0 | 0.6 | 0.2 | 0.4 | |||||||||
balance-sheet.row.other-current-assets | 0 | 0.4 | 0.9 | 7.1 | |||||||||
balance-sheet.row.total-current-assets | 0 | 18.3 | 22.6 | 55 | |||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 3 | 2.7 | 2.5 | |||||||||
balance-sheet.row.goodwill | 0 | 0.5 | 7 | 8.7 | |||||||||
balance-sheet.row.intangible-assets | 0 | 54.4 | 162.9 | 192.3 | |||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 54.4 | 169.9 | 201 | |||||||||
balance-sheet.row.long-term-investments | 0 | 53.9 | -7 | -8.7 | |||||||||
balance-sheet.row.tax-assets | 0 | 0.6 | 0.5 | 1.7 | |||||||||
balance-sheet.row.other-non-current-assets | 0 | -53.8 | 0.1 | 0.1 | |||||||||
balance-sheet.row.total-non-current-assets | 0 | 58.1 | 166.2 | 196.6 | |||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-assets | 0 | 76.4 | 188.8 | 251.6 | |||||||||
balance-sheet.row.account-payables | 0 | 1 | 1.6 | 1.7 | |||||||||
balance-sheet.row.short-term-debt | 0 | 2.2 | 2.1 | 1.7 | |||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0.3 | 0.5 | |||||||||
balance-sheet.row.long-term-debt-total | 0 | 0 | 0 | 0.4 | |||||||||
Deferred Revenue Non Current | 0 | 2.1 | 2.2 | 2.2 | |||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||
balance-sheet.row.other-current-liab | 0 | 3.6 | 6.2 | 15.9 | |||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 17.3 | 32.7 | 50.4 | |||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.capital-lease-obligations | 0 | 2.1 | 2.2 | 2.2 | |||||||||
balance-sheet.row.total-liab | 0 | 24.2 | 43.4 | 70.1 | |||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.common-stock | 0 | 56.2 | 56.2 | 44.1 | |||||||||
balance-sheet.row.retained-earnings | 0 | -218.3 | -119.6 | -69.8 | |||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 6.2 | 5.3 | 2.6 | |||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 208.2 | 203.6 | 204.5 | |||||||||
balance-sheet.row.total-stockholders-equity | 0 | 52.2 | 145.4 | 181.5 | |||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 76.4 | 188.8 | 251.6 | |||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-equity | 0 | 52.2 | 145.4 | 181.5 | |||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||
Total Investments | 0 | 53.9 | -7 | -8.7 | |||||||||
balance-sheet.row.total-debt | 0 | 4.3 | 4.3 | 4.3 | |||||||||
balance-sheet.row.net-debt | 0 | -10.2 | -14.9 | -40.5 |
Kapitalflussrechnung
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -50.8 | -34.7 | -7.8 | ||||||||
cash-flows.row.depreciation-and-amortization | 0 | 3.9 | 2 | 0.1 | ||||||||
cash-flows.row.deferred-income-tax | 0 | -3.5 | -0.8 | 1.6 | ||||||||
cash-flows.row.stock-based-compensation | 0 | 2.2 | 1.1 | 1 | ||||||||
cash-flows.row.change-in-working-capital | 0 | 5.6 | -5.2 | 0 | ||||||||
cash-flows.row.account-receivables | 0 | 0 | -0.2 | 0 | ||||||||
cash-flows.row.inventory | 0 | 0.2 | -0.1 | 0 | ||||||||
cash-flows.row.account-payables | 0 | -0.1 | -0.8 | 1.2 | ||||||||
cash-flows.row.other-working-capital | 0 | 5.5 | -4.1 | -1.2 | ||||||||
cash-flows.row.other-non-cash-items | 0 | 18.6 | 1.9 | -13.1 | ||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -0.5 | -13.7 | 0 | ||||||||
cash-flows.row.acquisitions-net | 0 | -7.9 | -16.7 | 0 | ||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | ||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0.5 | 0.1 | 3.3 | ||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | -0.2 | ||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -8 | -30.3 | 3 | ||||||||
cash-flows.row.debt-repayment | 0 | -0.1 | -5.6 | -0.5 | ||||||||
cash-flows.row.common-stock-issued | 0 | 7.1 | 76.1 | 58.3 | ||||||||
cash-flows.row.common-stock-repurchased | 0 | -0.2 | -2.8 | -0.6 | ||||||||
cash-flows.row.dividends-paid | 0 | -6.8 | -67.7 | -58.2 | ||||||||
cash-flows.row.other-financing-activites | 0 | 6.4 | 67.7 | 58.2 | ||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 6.4 | 67.7 | 58.2 | ||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0.2 | -0.1 | 0.1 | ||||||||
cash-flows.row.net-change-in-cash | 0 | -25.5 | 1.6 | 43 | ||||||||
cash-flows.row.cash-at-end-of-period | 0 | 19.2 | 44.8 | 43.2 | ||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 44.8 | 43.2 | 0.1 | ||||||||
cash-flows.row.operating-cash-flow | 0 | -24.1 | -35.7 | -18.2 | ||||||||
cash-flows.row.capital-expenditure | 0 | -0.5 | -13.7 | 0 | ||||||||
cash-flows.row.free-cash-flow | 0 | -24.6 | -49.4 | -18.2 |
Zeile der Gewinn- und Verlustrechnung
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 6 | 6.1 | 3.3 | |||||||||
income-statement-row.row.cost-of-revenue | 0 | 16.9 | 18.1 | 11.9 | |||||||||
income-statement-row.row.gross-profit | 0 | -10.9 | -12 | -8.6 | |||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||
income-statement-row.row.other-expenses | 0 | -0.2 | -1.3 | -0.7 | |||||||||
income-statement-row.row.operating-expenses | 0 | 9 | 24.5 | 26.6 | |||||||||
income-statement-row.row.cost-and-expenses | 0 | 25.9 | 42.6 | 38.5 | |||||||||
income-statement-row.row.interest-income | 0 | 0.1 | 0 | 0 | |||||||||
income-statement-row.row.interest-expense | 0 | 0.2 | 0.2 | 0.3 | |||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -91.8 | -17.8 | -0.3 | |||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||
income-statement-row.row.other-operating-expenses | 0 | -0.2 | -1.3 | -0.7 | |||||||||
income-statement-row.row.total-operating-expenses | 0 | -91.8 | -17.8 | -0.3 | |||||||||
income-statement-row.row.interest-expense | 0 | 0.2 | 0.2 | 0.3 | |||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 3.3 | 3.9 | 2 | |||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||
income-statement-row.row.operating-income | 0 | -19.9 | -36.5 | -35.2 | |||||||||
income-statement-row.row.income-before-tax | 0 | -111.7 | -54.3 | -35.5 | |||||||||
income-statement-row.row.income-tax-expense | 0 | -13.5 | -3.5 | -0.8 | |||||||||
income-statement-row.row.net-income | 0 | -98.2 | -50.8 | -34.7 |
Häufig gestellte Frage
Wie hoch ist die Relief Therapeutics Holding AG (0QKQ.L) Gesamtvermögen?
Relief Therapeutics Holding AG (0QKQ.L) Gesamtvermögen ist 76390000.000.
Wie hoch ist der Jahresumsatz des Unternehmens?
Der Jahresumsatz ist N/A.
Wie hoch ist die Gewinnspanne des Unternehmens?
Die Gewinnmarge des Unternehmens ist -1.800.
Wie hoch ist der freie Cashflow des Unternehmens?
Der freie Cashflow ist -1.433.
Wie hoch ist die Nettogewinnspanne des Unternehmens?
Die Nettogewinnmarge ist -16.274.
Wie hoch sind die Gesamteinnahmen des Unternehmens?
Der Gesamtertrag ist -3.299.
Was ist der Relief Therapeutics Holding AG (0QKQ.L) nettogewinn (reingewinn)?
Der Nettogewinn (Nettoeinkommen) ist -98181000.000.
Wie hoch ist die Gesamtverschuldung des Unternehmens?
Die Gesamtverschuldung ist 4311000.000.
Wie hoch ist der Betriebsaufwand?
Die Betriebsausgaben sind 9045000.000.
Wie hoch ist der Bargeldbestand des Unternehmens?
Die Unternehmensliquidität ist 0.000.